VFA
SGYP

Virtus Fund Advisers’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Virtus Fund Advisers’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,995
Closed -$33K – 2310
2014
Q2 		$33K Buy
+7,995
New +$34K ﹤0.01% 2144

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Virtus Fund Advisers's SGYP Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2014, closing a stake of 7,995 shares — an estimated $33K sold.

Virtus Fund Advisers first reported a position in SGYP in Q2 2014 and held it in 1 quarter. The position peaked at $33K in Q2 2014. 78 funds tracked by Wall St. Rank hold SGYP as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 7,995 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2014, an estimated $33K.
  • Virtus Fund Advisers first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Synergy Pharmaceuticals, Inc Common Stock position peaked at $33K in Q2 2014.
  • 78 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.